Novel Approaches for Preventing or Limiting Events (Naples) II Trial

Nitric oxide: an endogenous modulator of leukocyte adhesion.

Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,052 · see citing works

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

Task Force Members, Thygesen, K. A., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,536 · see citing works

Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors

Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837 · see citing works

Antiatherothrombotic Properties of Statins

Rosenson, R. S., & Tangney, C. (1998) · JAMA · doi:10.1001/jama.279.20.1643 · Cited by 959 · see citing works

Beneficial Cardiovascular Pleiotropic Effects of Statins

Davignon, J. (2004) · Circulation · doi:10.1161/01.cir.0000131517.20177.5a · Cited by 955 · see citing works

UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION

Thygesen, K. A., Alpert, J. S., & White, H. (2008) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2008-4-5-91-105 · Cited by 527 · see citing works

Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention

Pasceri, V., Patti, G., Nusca, A., Pristipino, C., Richichi, G., & Sciascio, G. D. (2004) · Circulation · doi:10.1161/01.cir.0000137828.06205.87 · Cited by 466 · see citing works

Simvastatin Preserves the Ischemic-Reperfused Myocardium in Normocholesterolemic Rat Hearts

Lefer, A. M., Campbell, B., Shin, Y.-K., Scalia, R. G., Hayward, R., & Lefer, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.2.178 · Cited by 326 · see citing works

Peri-procedural myocardial injury: 2005 update

Herrmann, J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi455 · Cited by 326 · see citing works

Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention

Di Sciascio, G., Patti, G., Pasceri, V., Gaspardone, A., Colonna, G., & Montinaro, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.028 · Cited by 315 · see citing works

Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect

Inoue, I., Goto, S.-I., Mizotani, K., Awata, T., Mastunaga, T., Kawai, S.-I., Nakajima, T., Hokari, S., Komoda, T., & Katayama, S. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00680-9 · Cited by 298 · see citing works

Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins

Romano, M., Diomede, L., Sironi, M., Massimiliano, L., Sottocorno, M., Polentarutti, N., Guglielmotti, A., Albani, D., Bruno, A., Fruscella, P., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780115 · Cited by 298 · see citing works

Prognostic Implication of Creatine Kinase Elevation Following Elective Coronary Artery Interventions

Kong, T. Q. (1997) · JAMA · doi:10.1001/jama.1997.03540300029029 · Cited by 280 · see citing works

Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathway

Bell, R. M., & Yellon, D. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02816-4 · Cited by 261 · see citing works

Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa Hypercholesterolemia

Notarbartolo, A., Davı̀, G., Averna, M. R., Barbagallo, C. M., Ganci, A., Giammarresi, C., Placa, F. L., & Patrono, C. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.247 · Cited by 259 · see citing works

HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells

Bourcier, T., & Libby, P. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.556 · Cited by 233 · see citing works

Death Following Creatine Kinase-MB Elevation After Coronary Intervention

Ellis, S. G., Chew, D. P., Chan, A. W., Whitlow, P. L., Schneider, J. P., & Topol, E. J. (2002) · Circulation · doi:10.1161/01.cir.0000028146.71416.2e · Cited by 209 · see citing works

Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study

Cavallini, C., Savonitto, S., Violini, R., Arraiz, G., Plebani, M., Olivari, Z., Rubartelli, P., Battaglia, S., Niccoli, L., Steffenino, G., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi173 · Cited by 203 · see citing works

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction

Briguori, C., Colombo, A., Airoldi, F., VIOLANTE, A., Focaccio, A., BALESTRIERI, P., PAOLOELIA, P., Golia, B., LEPORE, S., & Riviezzo, G. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.017 · Cited by 175 · see citing works

Statin Therapy in Acute Coronary Syndromes

Sposito, A. C., & Chapman, M. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000032033.39301.6a · Cited by 159 · see citing works

Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction

Ueda, Y., Kitakaze, M., Komamura, K., Minamino, T., Asanuma, H., Sato, H., Kuzuya, T., Takeda, H., & Hori, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00440-4 · Cited by 116 · see citing works

Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets

Hussein, O., Rosenblat, M., Schlezinger, S., Keidar, S., & Michael, A. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00625.x · Cited by 105 · see citing works

Pravastatin: An Antithrombotic Effect Independent of the Cholesterol-lowering Effect

Smith, D., Unger, A., Shao, J., Meraj, P., Fier, C., Cohen, A., Fallon, J., Badimon, J., Ambrose, J., & Dangas, G. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613893 · Cited by 103 · see citing works

The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctions

Steinhubl, S. R., Lauer, M. S., Mukherjee, D., Moliterno, D. J., Lincoff, A. M., Ellis, S. G., & Topol, E. J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00376-3 · Cited by 81 · see citing works

Platelet Cytosolic Ca 2+ and Membrane Dynamics in Patients With Primary Hypercholesterolemia

Sang, K. L. Q., Levenson, J. A., Mégnien, J. L., Simon, A. C., & Devynck, M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.6.759 · Cited by 77 · see citing works

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial

Blankenship, J. C., Tasissa, G., O’Shea, J. C., Iliadis, E. A., Bachour, F. A., Cohen, D. J., Lui, H. K., Mann, T., Cohen, E. A., & Tcheng, J. E. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01423-1 · Cited by 54 · see citing works

Meta-Analysis of Published Reports on the Effect of Statin Treatment Before Percutaneous Coronary Intervention on Periprocedural Myonecrosis

Merla, R., Reddy, N. K., Wang, F.-W., Uretsky, B. F., Barbagelata, A., & Birnbaum, Y. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.105 · Cited by 40 · see citing works

β-Blockers Before Percutaneous Coronary Intervention Do Not Attenuate Postprocedural Creatine Kinase Isoenzyme Rise

Ellis, S. G., Brener, S. J., Lincoff, A. M., Moliterno, D. J., Whitlow, P. L., Schneider, J. P., & Topol, E. J. (2001) · Circulation · doi:10.1161/hc4701.099782 · Cited by 34 · see citing works

The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction

Ošťádal, P., Alan, D., Hájek, P., Horak, D., Vejvoda, J., Trefanec, J., Mates, M., & Vojáček, J. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0298-2_7 · Cited by 33 · see citing works

Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention

Veselka, J., Procházková, Š., Duchoňová, R., Homolová, I., Tesař, D., & Bybee, K. A. (2006) · Heart and Vessels · doi:10.1007/s00380-005-0885-x · Cited by 28 · see citing works

The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in patients with unstable angina and non-Q-wave myocadial infarction

Ošťádal, P., Alan, D., Hajek, P., Horak, D., Vejvoda, J., Trefanec, J., Mates, M., & Vojacek, J. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1023499727477 · Cited by 20 · see citing works

Statin administration before percutaneous coronary intervention: Impact on periprocedural myocardial infarction

Briguori, C., Colombo, A., & Airoldi, F. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.12.105 · Cited by 9 · see citing works

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961 · see citing works

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854 · see citing works

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289 · see citing works

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162 · see citing works

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,165 · see citing works

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582 · see citing works

ESC/EAS Guidelines for the management of dyslipidaemias

Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706 · see citing works

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary

Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823a5596 · Cited by 631 · see citing works

The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction

Chaitman, B. R., Hardison, R. M., Adler, D., Gebhart, S., Grogan, M., Ocampo, S., Sopko, G., Ramires, J. A., Schneider, D., Frye, R. L., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.913111 · Cited by 263 · see citing works

Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction

Tardif, J., Tanguay, J., Wright, S. R., Duchatelle, V., Petroni, T., Grégoire, J. C., Ibrahim, R., Heinonen, T. M., Robb, S., Bertrand, O. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.003 · Cited by 206 · see citing works

Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection

Babu, G. G., Walker, J. M., Yellon, D. M., & Hausenloy, D. J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq393 · Cited by 193 · see citing works

Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention

Patti, G., Cannon, C. P., Murphy, S. A., Mega, S., Pasceri, V., Briguori, C., Colombo, A., Yun, K. H., Jeong, M. H., Kim, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.002451 · Cited by 188 · see citing works

Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention

Shah, B., Pillinger, M. H., Zhong, J., Cronstein, B. N., Xia, Y., Lorin, J. D., Smilowitz, N. R., Feit, F., Ratnapala, N., Keller, N. M., et al. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.119.008717 · Cited by 190 · see citing works

Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury

Quintavalle, C., Fiore, D., Micco, F. D., Visconti, G., Focaccio, A., Golia, B., Ricciardelli, B., Donnarumma, E., Bianco, A., Zabatta, M. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.103317 · Cited by 186 · see citing works

Efficacy of High-Dose Atorvastatin Loading Before Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction

Kim, J.-S., Kim, J., Choi, D., Lee, C. J., Lee, S. H., Ko, Y.-G., Hong, M.-K., Kim, B.-K., Oh, S. J., Jeon, D. W., et al. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.11.021 · Cited by 183 · see citing works

Evidence of Pre-Procedural Statin Therapy

Winchester, D. E., Wen, X., Xie, L. X., & Bavry, A. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.023 · Cited by 173 · see citing works

2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary

Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2012) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23438 · Cited by 166 · see citing works

Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials

Rahimi, K., Emberson, J., McGale, P., Majoni, W., Merhi, A., Asselbergs, F. W., Krane, V., Macfarlane, P. W., & Executive, P. I. A. O. B. O. T. P. (2011) · BMJ · doi:10.1136/bmj.d1250 · Cited by 159 · see citing works

2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention

Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23390 · Cited by 146 · see citing works

Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection

Heusch, G., Andreadou, I., Bell, R., Bertero, E., Bøtker, H. E., Davidson, S. M., Downey, J. M., Eaton, P., Ferdinandy, P., Gersh, B. J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102894 · Cited by 140 · see citing works

Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial

Berwanger, O., Santucci, E. V., de Barros e Silva, P. G. M., Jesuíno, I. D. A., Damiani, L. P., Barbosa, L. M., Santos, R. H. N., Laranjeira, L. N., Egydio, F. D. M., Borges de Oliveira, J. A., et al. (2018) · JAMA · doi:10.1001/jama.2018.2444 · Cited by 131 · see citing works

Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Bulluck, H., Paradies, V., Barbato, E., Baumbach, A., Bøtker, H. E., Capodanno, D., Caterina, R. D., Cavallini, C., Davidson, S. M., Feldman, D. N., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab271 · Cited by 133 · see citing works

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary

Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.006 · Cited by 107 · see citing works

The Pleiotropic Effects of the Hydroxy-Methyl-Glutaryl-CoA Reductase Inhibitors in Cardiovascular Disease

Mihos, C. G., Salas, M. J., & Santana, O. (2010) · Cardiology in Review · doi:10.1097/crd.0b013e3181f52a7f · Cited by 95 · see citing works

Timing of Pre-Operative Beta-Blocker Treatment in Vascular Surgery Patients

Flu, W., van Kuijk, J., Chonchol, M., Winkel, T. A., Verhagen, H. J. M., Bax, J. J., & Poldermans, D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.056 · Cited by 80 · see citing works

Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy

Sharma, V., Bell, R. M., & Yellon, D. M. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.685163 · Cited by 77 · see citing works

A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Tardif, J., L’Allier, P. L., Grégoire, J. C., Ibrahim, R., McFadden, G., Kostuk, W. J., Knudtson, M. L., Labinaz, M. X., Waksman, R., Pepine, C. J., et al. (2010) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.110.953885 · Cited by 72 · see citing works

HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass

Lewicki, M. C., Ng, I., & Schneider, A. G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010480.pub2 · Cited by 69 · see citing works

Preoperative cardiac management of the patient for non-cardiac surgery: an individualized and evidence-based approach

Priebe, H.-J. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer121 · Cited by 69 · see citing works

Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?: Table 1

Cuculi, F., Lim, C. C. S., & BANNING, A. P. (2010) · Heart · doi:10.1136/hrt.2009.186189 · Cited by 67 · see citing works

Impact of Coronary Plaque Composition on Cardiac Troponin Elevation After Percutaneous Coronary Intervention in Stable Angina Pectoris

Watabe, H., Sato, A., Akiyama, D., Kakefuda, Y., Adachi, T., Ojima, E., Hoshi, T., Murakoshi, N., Ishizu, T., Seo, Y., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.051 · Cited by 66 · see citing works

Pleiotropic Effects of Statins

Marzilli, M. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/1153644-s0-000000000-00000 · Cited by 60 · see citing works

Advances in treatment strategies for ischemia reperfusion injury

Pantazi, E. D., Béjaoui, M., Folch‐Puy, E., Adam, R. A., & Roselló‐Catafau, J. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1115015 · Cited by 60 · see citing works

Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial

Cole, J., Htun, N., Lew, R., Freilich, M. I., Quinn, S. J., & Layland, J. J. (2021) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.009992 · Cited by 58 · see citing works

Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Hahn, J., Kim, H.-J., Choi, Y. J., Jo, S., Kim, H. J., Lee, S., Ahn, K.-J., Song, Y. B., Choi, J., Choi, S., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.08.011 · Cited by 56 · see citing works

Inflammation during Percutaneous Coronary Intervention—Prognostic Value, Mechanisms and Therapeutic Targets

Tucker, B., Vaidya, K., Cochran, B. J., & Patel, S. (2021) · Cells · doi:10.3390/cells10061391 · Cited by 57 · see citing works

Molecular mechanism of statin-mediated LOX-1 inhibition

Biocca, S., Iacovelli, F., Matarazzo, S., Vindigni, G., Oteri, F., Desideri, A., & Falconi, M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1026486 · Cited by 53 · see citing works

White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era

Shah, B., Baber, U., Pocock, S., Krucoff, M. W., Ariti, C. A., Gibson, C. M., Steg, P. G., Weisz, G., Witzenbichler, B., Henry, T. D., et al. (2017) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.117.004981 · Cited by 53 · see citing works

Inhibition of p38 Mitogen-Activated Protein Kinase Reduces Inflammation After Coronary Vascular Injury in Humans

Sarov‐Blat, L., Morgan, J. M., Fernandez, P., James, R., Fang, Z., Hurle, M. R., Baidoo, C. A., Willette, R. N., Lepore, J. J., Jensen, S. E., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.209205 · Cited by 52 · see citing works

New Universal Definition of Myocardial Infarction

Locca, D., Bucciarelli‐Ducci, C., Ferrante, G., Manna, A. L., Keenan, N., Grasso, A. E., Barlis, P., Furia, F. D., Prasad, S. K., Kaski, J. C., et al. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.06.015 · Cited by 50 · see citing works

Prevention of Peri-procedural Myocardial Injury Using a Single High Loading Dose of Rosuvastatin

Çay, S., Cagirci, G., Şen, N., Balbay, Y., Durmaz, T., & Aydoğdu, S. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6224-1 · Cited by 48 · see citing works

Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial

Sardella, G., Lucisano, L., Mancone, M., Conti, G., Calcagno, S., Stio, R. E., Pennacchi, M., Biondi‐Zoccai, G., Canali, E., & Fedele, F. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.06.017 · Cited by 42 · see citing works

Managing Coronary Artery Disease in the Cancer Patient

Krone, R. J. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.06.004 · Cited by 41 · see citing works

High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: A meta‐analysis of randomized controlled trials

Benjo, A. M., El‐Hayek, G. E., Messerli, F. H., DiNicolantonio, J. J., Hong, M. K., Aziz, E. F., Herzog, E., & Tamis‐Holland, J. E. (2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25302 · Cited by 39 · see citing works

Relation Between the Presence and Extent of Coronary Lipid Core Plaques Detected by Near-Infrared Spectroscopy With Postpercutaneous Coronary Intervention Myocardial Infarction

Raghunathan, D., Abdel-karim, A.-R. R., Papayannis, A., DaSilva, M., Jeroudi, O. M., Rangan, B. V., Banerjee, S., & Brilakis, E. S. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.044 · Cited by 38 · see citing works

Do structural differences in statins correlate with clinical efficacy?

Arnaboldi, L., & Corsini, A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833b776c · Cited by 35 · see citing works

Periprocedural Myocardial Infarction: Review and Classification

Hanna, E. B., & Hennebry, T. A. (2010) · Clinical Cardiology · doi:10.1002/clc.20819 · Cited by 34 · see citing works

Effect of High Dose Rosuvastatin Loading before Primary Percutaneous Coronary Intervention on Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction

Kim, J. W., Yun, K. H., Kim, E. K., Kim, Y., Joe, D., Ko, J. S., Rhee, S. J., Lee, E. M., Yoo, N. J., Kim, N., et al. (2014) · Korean Circulation Journal · doi:10.4070/kcj.2014.44.2.76 · Cited by 34 · see citing works

Washed microbiota transplantation improves patients with metabolic syndrome in South China

Wu, L., Lu, X., Lin, D.-J., Chen, W.-J., Xue, X.-Y., Liu, T., Xu, J., Xie, Y.-T., Li, M.-Q., Lin, W.-Y., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1044957 · Cited by 34 · see citing works

Therapeutic advances in myocardial microvascular resistance: Unravelling the enigma

Patel, B., & Fisher, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.014 · Cited by 34 · see citing works

Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: The ROMA trial

Sardella, G., Conti, G., Donahue, M. E., Mancone, M., Canali, E., Carlo, C. D., Roma, A. D., Calcagno, S., Lucisano, L., & Fedele, F. (2012) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.24403 · Cited by 33 · see citing works

Effect of a Single High Loading Dose of Rosuvastatin on Percutaneous Coronary Intervention for Acute Coronary Syndromes

Wang, Z., Dai, H., Xing, M., Yu, Z., Lin, X., Wang, S., Zhang, J., Hou, F., Ma, Y., Ren, Y., et al. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412474346 · Cited by 33 · see citing works

Administration of a Loading Dose of Atorvastatin Before Percutaneous Coronary Intervention Prevents Inflammation and Reduces Myocardial Injury in STEMI Patients: A Randomized Clinical Study

Liu, H., Yang, Y., Yang, S., Luo, J.-P., Li, H., Jing, L., & Shen, Z.-Q. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.01.009 · Cited by 33 · see citing works

Statin treatment before percutaneous cononary intervention.

Leoncini, M., Toso, A., Maioli, M., Tropeano, F., & Bellandi, F. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.05.09 · Cited by 32 · see citing works

The Anti-Ischemic and Anti-Anginal Properties of Statins

Lardizabal, J. A., & DEEDWANIA, P. C. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0147-y · Cited by 32 · see citing works

The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome

Sexton, T. R., Wallace, E. L., Macaulay, T. E., Charnigo, R. J., Evangelista, V., Campbell, C. L., Bailey, A. L., & Smyth, S. S. (2014) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-014-1142-x · Cited by 31 · see citing works

Effect of pre-procedural statin therapy on myocardial no-reflow following percutaneous coronary intervention: a meta analysis

Li, X., Yang, Y., Hao, Y., Yang, Y., Zhao, J., Dou, K., & Gu, D. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20122700 · Cited by 31 · see citing works

Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion

Zhao, X. J., Liu, X. L., He, G., & Xu, H. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132999 · Cited by 30 · see citing works

Do Statins have a Role in Reduction/Prevention of Post‐PCI Restenosis?

Prasad, K. (2011) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00302.x · Cited by 30 · see citing works

Pharmacological approaches to coronary microvascular dysfunction

Guarini, G., Huqi, A., Morrone, D., Capozza, P., Todiere, G., & Marzilli, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.008 · Cited by 30 · see citing works

Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction

García-Méndez, R. C., Almeida‐Gutiérrez, E., Serrano-Cuevas, L., Díaz, J. S. S., Rosas-Peralta, M., Ortega‐Ramírez, J. A., Villada, J. A. P., Isordia‐Salas, I., Bravo, R. M. A., & Borrayo–Sánchez, G. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.10.006 · Cited by 29 · see citing works

High-Dose Statin Pretreatment Decreases Periprocedural Myocardial Infarction and Cardiovascular Events in Patients Undergoing Elective Percutaneous Coronary Intervention: A Meta-Analysis of Twenty-Four Randomized Controlled Trials

Wang, L., Peng, P., Zhang, O., Xu, X., Yang, S., Zhao, Y., & Zhou, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113352 · Cited by 29 · see citing works

Impact of High Loading Dose of Atorvastatin in Diabetic Patients with Renal Dysfunction Undergoing Elective Percutaneous Coronary Intervention: A Randomized Controlled Trial

Shehata, M., & Hamza, M. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12108 · Cited by 28 · see citing works

Relation of intensity of statin therapy and outcomes after transcatheter aortic valve replacement

Huded, C. P., Benck, L. R., Stone, N. J., Sweis, R. N., Ricciardi, M. J., Malaisrie, S. C., Davidson, C. J., & Flaherty, J. D. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.02.042 · Cited by 27 · see citing works

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned, J., BANNING, A. P., Farooq, V., Pinto, M. E., Onuma, Y., Ryan, N., Cavalcante, R., Campos, C. M., Stanetić, B., Ishibashi, Y., et al. (2016) · EuroIntervention · doi:10.4244/eijv12i2a36 · Cited by 27 · see citing works

Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease

Yang, C., Wu, Y., Qian, J., & Li, J. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2412373 · Cited by 27 · see citing works

Pre‐loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI

Lampropoulos, K. M., Megalou, A. J., Bazoukis, G., Tse, G., & Manolis, A. S. (2017) · Journal of Interventional Cardiology · doi:10.1111/joic.12421 · Cited by 27 · see citing works

Update on the efficacy of statin treatment in acute coronary syndromes

Rosa, G. M., Carbone, F., Parodi, A., Massimelli, E. A., Brunelli, C., Mach, F., Vuilleumier, N., & Montecucco, F. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12255 · Cited by 26 · see citing works

Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study)

Ricottini, E., Madonna, R., Grieco, D., Zoccoli, A., Stampachiacchiere, B., Patti, G., Tonini, G., Caterina, R. D., & Sciascio, G. D. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.10.043 · Cited by 26 · see citing works

Can a High Reloading Dose of Atorvastatin Prior to Percutaneous Coronary Intervention Reduce Periprocedural Myocardial Infarction?

Nafasi, L., Rahmani, R., Shafiee, A., Salari, A., Abdollahi, A., & Meysamie, A. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.834249 · Cited by 25 · see citing works

Efficacy of Early Intensive Rosuvastatin Therapy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (ROSEMARY Study)

Ko, Y., Won, H., Shin, D., Kim, J., Kim, B., Choi, D., Hong, M., Bae, J., Lee, S., Lim, D., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.03.059 · Cited by 24 · see citing works

High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction

Gavazzoni, M., Gorga, E., Derosa, G., Maffioli, P., Metra, M., & Raddino, R. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s135173 · Cited by 23 · see citing works

High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass

Kotani, Y., Kataoka, Y., Izawa, J., Fujioka, S., Yoshida, T., Kumasawa, J., & Kwong, J. S. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013494.pub2 · Cited by 22 · see citing works

Intensive Atorvastatin Therapy Attenuates the Inflammatory Responses in Monocytes of Patients with Unstable Angina Undergoing Percutaneous Coronary Intervention via Peroxisome Proliferator-Activated Receptor γ Activation

Yang, J., Liu, C., Linxia, Z., Liu, Y., Guo, A.-H., Shi, H., Liu, X., & Cheng, Y. (2015) · Inflammation · doi:10.1007/s10753-015-0116-2 · Cited by 22 · see citing works

Adverse clinical outcomes in patients undergoing both PCI and TAVR : Analysis from a pooled multi‐center registry

Kumar, A., Sammour, Y. M., Reginauld, S., Sato, K., Agrawal, N., Lee, J. M., Meenakshisundaram, C., Ramanan, T., Kamioka, N., Sawant, A. C., et al. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29233 · Cited by 22 · see citing works

Periprocedural myocardial infarction and injury

Spagnolo, M., Occhipinti, G., Laudani, C., Greco, A., & Capodanno, D. (2024) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuae014 · Cited by 21 · see citing works

Usefulness of Rosuvastatin to Prevent Periprocedural Myocardial Injury in Patients Undergoing Elective Coronary Intervention

Takano, H., Ohba, T., Yamamoto, E., Miyachi, H., Inui, K., Kawanaka, H., Kamiya, M., Kikuchi, A., Takahashi, Y., Tanabe, J., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.02.018 · Cited by 21 · see citing works

Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study)

Eisen, A., Leshem‐Lev, D., Yavin, H. D., Orvin, K., Mager, A., Rechavia, E., Bental, T., Dadush, O., Battler, A., Kornowski, R., et al. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6575-8 · Cited by 21 · see citing works

Effect of High‐Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta‐analysis

Zhai, C., Cong, H., Liu, Y., Zhang, Y., Liu, X., Zhang, H., & Ren, Z. (2015) · Clinical Cardiology · doi:10.1002/clc.22471 · Cited by 21 · see citing works

Meta‐analysis of the role of high‐dose statins administered prior to percutaneous coronary intervention in reducing major adverse cardiac events in patients with coronary artery disease

Hao, P., Chen, Y., Wang, J., Ji, W., Li, X., Liu, X., Wang, X., & Zhang, Y. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05339.x · Cited by 19 · see citing works

Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study

Zemánek, D., Branny, M., Martinkovičová, L., Hájek, P., Malý, M., Tesař, D., Tomašov, P., & Veselka, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.002 · Cited by 19 · see citing works

Predictors and Periprocedural Myocardial Injury Rate of Small Side Branches Occlusion in Coronary Bifurcation Intervention

Zhang, D., Xu, B., Yin, D., Li, Y., He, Y., You, S., Qiao, S., Wu, Y., Yan, H., Yang, Y., et al. (2015) · Medicine · doi:10.1097/md.0000000000000992 · Cited by 19 · see citing works

Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction

Toso, A., Leoncini, M., Maioli, M., Gallopin, M., Tedeschi, D., Amato, M., & Bellandi, F. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328341024f · Cited by 19 · see citing works

Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?

Lee, B., Koo, B., Nam, C., Doh, J., Chung, W., Cho, B. R., & Fearon, W. F. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.4.472 · Cited by 18 · see citing works

Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial

Aslanabadi, N., Jafaripour, I., Sadeghi, S., Hamishehkar, H., Ghaffari, S., Toluey, M., Azizi, H., & Entezari‐Maleki, T. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.989 · Cited by 18 · see citing works

Effect of Two-Day Atorvastatin Pretreatment on Long-Term Outcome of Patients With Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention

Veselka, J., Zemánek, D., Hájek, P., Malý, M., Adlová, R., Martinkovičová, L., Tomašov, P., & Tesař, D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.12.040 · Cited by 17 · see citing works

Short-term intensive atorvastatin therapy improves endothelial function partly via attenuating perivascular adipose tissue inflammation through 5-lipoxygenase pathway in hyperlipidemic rabbits

Xiaoqiao, W., Yongqin, L., Nian-sang, L., Zhongqing, C., Gu, M.-N., Jingfeng, W., & Yangxin, C. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20133011 · Cited by 17 · see citing works

Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: A clinical study

Li, Q., Deng, S., Xia, S., Du, J., & She, Q. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.05.042 · Cited by 17 · see citing works

Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte Interactions

Sexton, T. R., Wallace, E., & Smyth, S. S. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666160504100312 · Cited by 17 · see citing works

The Role of Statins in Preventing Contrast-Induced Acute Kidney Injury

Akyüz, Ş., Yaylak, B., Altay, S., Kaşıkçıoğlu, H., & Çam, N. (2014) · Angiology · doi:10.1177/0003319714549556 · Cited by 16 · see citing works

High-dose atorvastatin for preventing contrast-induced nephropathy in primary percutaneous coronary intervention

Jo, S., Hahn, J., Lee, S. Y., Kim, H. J., Song, Y. B., Choi, J., Choi, S., Lee, S. H., & Gwon, H. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000157 · Cited by 16 · see citing works

Radial Artery Catheterization for Percutaneous Vascular or Coronary Interventions: An Innocent Procedure?

Paraskevas, K. I., Anastasakis, E., Andrikopoulou, M., & Mikhailidis, D. P. (2009) · Angiology · doi:10.1177/0003319709353169 · Cited by 15 · see citing works

Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?

Athyros, V. G., Τζιόμαλος, Κ., Florentin, M., Karagiannis, A. I., & Mikhailidis, D. P. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003634338 · Cited by 15 · see citing works

Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India

Roy, D., Mahapatra, T., Manna, K., Kar, A., Rana, M. S., Roy, A., Bose, P. K., Banerjee, B., Paul, S., & Chakraborty, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233230 · Cited by 14 · see citing works

Preprocedural statin therapy, inflammation, and myocardial injury in low‐risk stable coronary artery disease patients submitted to coronary stent implantation

Greque, G. V., Junior, C. V. S., Strunz, C. M. C., Soeiro, A. M., dos Santos, M. A., Pivatelli, F. C., Jl, J., Pesaro, A. E. P., Nicolau, J. C., & Filho, R. K. (2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.24937 · Cited by 14 · see citing works

The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention

Aslanabadi, N., Safaie, N., Asgharzadeh, Y., Houshmand, F., Ghaffari, S., Garjani, A., Dousti, S., Hamishehkar, H., & Entezari‐Maleki, T. (2016) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12195 · Cited by 14 · see citing works

Effect of High-Dose Statin Pretreatment for Myocardial Perfusion in Patients Receiving Percutaneous Coronary Intervention (PCI): A Meta-Analysis of 15 Randomized Studies

Xiao, Y., He, S., Zhang, Z., Feng, H., Cui, S., & Wu, J. (2018) · Medical Science Monitor · doi:10.12659/msm.911921 · Cited by 14 · see citing works

Association of baseline C‐reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: A CACTUS study subanalysis

Niccoli, G., Sgueglia, G. A., Latib, A., Crea, F., Colombo, A., & on behalf of the CACTUS Study Group (2013) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25102 · Cited by 13 · see citing works

Impact of Long-term Statin Therapy on Postprocedural Myocardial Infarction in Patients Undergoing Nonemergency Percutaneous Coronary Intervention

Gordin, J. S., Haider, A., Swaminathan, R. V., Kim, L. K., Minutello, R. M., Bergman, G. W., Wong, S. C., & Feldman, D. N. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.06.052 · Cited by 13 · see citing works

Efficacy and safety of serial atorvastatin load in Chinese patients undergoing elective percutaneous coronary intervention: results of the ISCAP (Intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) randomized controlled trial

Zheng, B., Jiang, J., Liu, H., Zhang, J. J., Li, H., Su, X., Wang, H., Song, Z., Han, Y., Lei, H., et al. (2015) · European Heart Journal Supplements · doi:10.1093/eurheartj/suv021 · Cited by 13 · see citing works

Can a High Reloading Dose of Atorvastatin Prior to Percutaneous Coronary Intervention Reduce Periprocedural Myocardial Infarction?

Nafasi, L., Rahmani, R., Shafiee, A., Salari, A., Abdollahi, A., & Meysamie, A. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.834249 · Cited by 25 · see citing works

Impact of a Single High Loading Dose of Atorvastatin before Percutaneous Coronary Intervention on Incidence of PCI-Related Myocardial Infarction

Lianbin, W. (2013) · Clinical Medicine & Engineering

AS-263 Effect of High-dose Statin Pretreatment of Perip-procedural Myocardial Injury during Elective Percutaneous Coronary Intervention in Real World

Ha, S. J., Kim, W., Yu, T. K., Woo, J. S., Kim, S., Kim, M. K., & Kim, K. S. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.02.266

Effects of single high loading dose of atorvastatin on periprocedural cardiac markers and myocardial infarction

Yingji, X. (2010) · International Journal of Cardiovascular Disease

Evaluation of high dose atorvastatin therapy 24 hours before elective percutaneous coronary intervention on peri-PCI myocardial infarction

Rahmani, R., Nafasi, L., Salary, A., Meisami, A. P., & Abdollahi, A. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)